Peripheral Vascular Stent Market Size, Share, and Trends Analysis | Global | 2024-2030 | MedCore | Includes: Arterial, Bare-Metal, Covered, Drug-Eluting, Venous Stent Markets

  • Year: 2024
  • Scope: 10 Years
  • Region: Global
  • Published Date: 2023/11/06
  • Type: MedCore

Product Description

Overall, the global peripheral vascular stent market was valued at $2.7 million in 2023. This is expected to increase over the forecast period at a CAGR of 3.1% to reach $3.3 million.

Throughout this medical market research, we analyzed over 20 peripheral vascular stent companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for peripheral vascular stents extends its projections up to the year 2030, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.

DATA TYPES INCLUDED

  • Unit SalesAverage Selling PricesMarket Value & Growth Trends
  • Forecasts Until 2030, and Historical Data to 2020
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • COVID19 Impact
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Global Peripheral Vascular Stent Market Insights

Global Peripheral Vascular Stent Market

Stents are commonly combined with other medical procedures such as atherectomies, interventions for chronic total occlusion, and cryoplasty. The growing adoption of these combination therapies with stents is attributed to their proven track record in maintaining open blood vessels over the long term, consequently boosting stent sales.

Global Peripheral Vascular Stent Market Share Insights

Global Peripheral Vascular Stent Market

  • In 2015, Medtronic established a leading position in the traditional bare-metal (BMS) market, especially in iliac and fem-pop segments, through the acquisition of Covidien. The approval of the Abre® stent in 2023 is expected to further enhance Medtronic‘s global market presence.
  • Boston Scientific has a significant presence in the iliac and renal stent segments with Express® LD iliac stent and Express® SD stents. In the venous stenting market, leveraging its historical market share with Wallstent™, the company successfully introduced the VICI® stent in 2013.
  • Becton Dickinson excels in the covered stent and BMS segments. E-LUMINEXX® and LIFESTENT® serve iliac and fem-pop arteries, respectively. Becton Dickinson‘s presence was particularly robust in the fem-pop BMS market in 2023.

Market Segmentation Summary

  • Arterial Stent Market
  • Bare-Metal Stent Market
  • Covered Stent Market
  • Drug-Eluting Stent Market
  • Venous Stent Market

Global Research Scope Summary

Report AttributeDetails
RegionsNorth America (Canada, United States)
Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela)
Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.)
Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine)
Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam)
Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year2023
Forecast2024-2030
Historical Data2020-2023
Quantitative CoverageMarket Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative CoverageCOVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data SourcesPrimary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

CONTACT US FOR ADDITIONAL INFORMATION

For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.

 

FREE Sample Report

Peripheral Vascular Stent Market
6.1 Executive Summary
6.1.1 Global Peripheral Vascular Stent Market Overview
6.1.2 Competitive Analysis
6.1.3 Procedures Included
6.1.4 Markets Included
6.1.5 Regions Included
6.2 Introduction
6.2.1 Peripheral Arterial Stents
6.2.1.1 Off-Label Use
6.2.1.2 Covered Stents
6.2.1.3 Drug-Eluting Stents
6.2.1.4 Stent Length
6.2.2 Venous Stents
6.3 Procedure Numbers
6.3.1 Total Peripheral Vascular Stenting Procedures
6.3.2 Arterial Stent Procedures
6.3.2.1 Bare-Metal Stent Procedures
6.3.2.2 Covered Stent Procedures
6.3.2.3 Drug-Eluting Stent Procedures
6.3.3 Venous Stent Procedures
6.4 Market Overview
6.4.1 By Segment
6.4.2 By Region
6.5 Market Analysis and Forecast
6.5.1 Arterial Stent Market
6.5.1.1 Bare-Metal Stent Market
6.5.1.1.1 Bare-Metal Carotid Stent Market
6.5.1.1.2 Bare-Metal Iliac Stent Market
6.5.1.1.3 Bare-Metal Renal Stent Market
6.5.1.1.4 Bare-Metal Fem-Pop Stent Market
6.5.1.1.5 Bare-Metal Infra-Pop Stent Market
6.5.1.2 Covered Stent Market
6.5.1.3 Drug-Eluting Stent Market
6.5.2 Venous Stent Market
6.6 Drivers and Limiters
6.6.1 Market Drivers
6.6.2 Market Limiters
6.7 Competitive Market Share Analysis
W.L. Gore
Boston Scientific
Abbott Vascular
Becton Dickinson
Medtronic
Cook Medical
Cardinal Health
Maquet
Others
Chart 6‑1: Peripheral Vascular Stent Market, Global, 2023 & 2030
Chart 6‑2: Peripheral Vascular Stent Procedures, Global, 2023
Chart 6‑3: Peripheral Vascular Stenting Procedures by Region, Global, 2020 – 2030
Chart 6‑4: Peripheral Vascular Stent Market by Segment, Global, 2020 – 2030
Chart 6‑5: Peripheral Vascular Stent Market by Region, Global, 2020 – 2030
Chart 6‑6: Leading Competitors, Peripheral Vascular Stent Market, Global, 2023
Figure 6‑1: Peripheral Vascular Stent Procedures Covered
Figure 6‑2: Peripheral Vascular Stent Markets Covered
Figure 6‑3: Peripheral Vascular Stent Regions Covered, Global (1 of 2)
Figure 6‑4: Peripheral Vascular Stent Regions Covered, Global (2 of 2)
Figure 6‑5: Peripheral Vascular Stenting Procedures by Segment, Global, 2020 – 2030
Figure 6‑6: Peripheral Vascular Stenting Procedures by Region, Global, 2020 – 2030
Figure 6‑7: Peripheral Vascular Stenting Procedures by Country, North America, 2020 – 2030
Figure 6‑8: Peripheral Vascular Stenting Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 6‑9: Peripheral Vascular Stenting Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 6‑10: Peripheral Vascular Stenting Procedures by Country, Western Europe, 2020 – 2030
Figure 6‑11: Peripheral Vascular Stenting Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 6‑12: Peripheral Vascular Stenting Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 6‑13: Peripheral Vascular Stenting Procedures by Country, Middle East, 2020 – 2030
Figure 6‑14: Peripheral Vascular Stenting Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 6‑15: Peripheral Vascular Stenting Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 6‑16: Peripheral Vascular Stenting Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 6‑17: Peripheral Vascular Stenting Procedures by Country, Africa, 2020 – 2030
Figure 6‑18: Arterial Stent Procedures by Segment, Global, 2020 – 2030
Figure 6‑19: Arterial Stent Procedures by Region, Global, 2020 – 2030
Figure 6‑20: Arterial Stent Procedures by Country, North America, 2020 – 2030
Figure 6‑21: Arterial Stent Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 6‑22: Arterial Stent Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 6‑23: Arterial Stent Procedures by Country, Western Europe, 2020 – 2030
Figure 6‑24: Arterial Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 6‑25: Arterial Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 6‑26: Arterial Stent Procedures by Country, Middle East, 2020 – 2030
Figure 6‑27: Arterial Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 6‑28: Arterial Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 6‑29: Arterial Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 6‑30: Arterial Stent Procedures by Country, Africa, 2020 – 2030
Figure 6‑31: Bare-Metal Stent Procedures by Region, Global, 2020 – 2030
Figure 6‑32: Bare-Metal Stent Procedures by Country, North America, 2020 – 2030
Figure 6‑33: Bare-Metal Stent Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 6‑34: Bare-Metal Stent Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 6‑35: Bare-Metal Stent Procedures by Country, Western Europe, 2020 – 2030
Figure 6‑36: Bare-Metal Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 6‑37: Bare-Metal Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 6‑38: Bare-Metal Stent Procedures by Country, Middle East, 2020 – 2030
Figure 6‑39: Bare-Metal Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 6‑40: Bare-Metal Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 6‑41: Bare-Metal Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 6‑42: Bare-Metal Stent Procedures by Country, Africa, 2020 – 2030
Figure 6‑43: Covered Stent Procedures by Region, Global, 2020 – 2030
Figure 6‑44: Covered Stent Procedures by Country, North America, 2020 – 2030
Figure 6‑45: Covered Stent Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 6‑46: Covered Stent Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 6‑47: Covered Stent Procedures by Country, Western Europe, 2020 – 2030
Figure 6‑48: Covered Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 6‑49: Covered Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 6‑50: Covered Stent Procedures by Country, Middle East, 2020 – 2030
Figure 6‑51: Covered Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 6‑52: Covered Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 6‑53: Covered Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 6‑54: Covered Stent Procedures by Country, Africa, 2020 – 2030
Figure 6‑55: Drug-Eluting Stent Procedures by Region, Global, 2020 – 2030
Figure 6‑56: Drug-Eluting Stent Procedures by Country, North America, 2020 – 2030
Figure 6‑57: Drug-Eluting Stent Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 6‑58: Drug-Eluting Stent Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 6‑59: Drug-Eluting Stent Procedures by Country, Western Europe, 2020 – 2030
Figure 6‑60: Drug-Eluting Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 6‑61: Drug-Eluting Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 6‑62: Drug-Eluting Stent Procedures by Country, Middle East, 2020 – 2030
Figure 6‑63: Drug-Eluting Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 6‑64: Drug-Eluting Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 6‑65: Drug-Eluting Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 6‑66: Drug-Eluting Stent Procedures by Country, Africa, 2020 – 2030
Figure 6‑67: Venous Stent Procedures by Region, Global, 2020 – 2030
Figure 6‑68: Venous Stent Procedures by Country, North America, 2020 – 2030
Figure 6‑69: Venous Stent Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 6‑70: Venous Stent Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 6‑71: Venous Stent Procedures by Country, Western Europe, 2020 – 2030
Figure 6‑72: Venous Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 6‑73: Venous Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 6‑74: Venous Stent Procedures by Country, Middle East, 2020 – 2030
Figure 6‑75: Venous Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 6‑76: Venous Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 6‑77: Venous Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 6‑78: Venous Stent Procedures by Country, Africa, 2020 – 2030
Figure 6‑79: Peripheral Vascular Stent Market by Segment, Global, 2020 – 2030 (US$M)
Figure 6‑80: Peripheral Vascular Stent Market by Region, Global, 2020 – 2030 (US$M)
Figure 6‑81: Arterial Stent Market by Segment, Global, 2020 – 2030 (US$M)
Figure 6‑82: Total Arterial Stent Market, Global, 2020 – 2030
Figure 6‑83: Units Sold by Region, Arterial Stent Market, Global, 2020 – 2030
Figure 6‑84: Average Selling Price by Region, Arterial Stent Market, Global, 2020 – 2030 (US$)
Figure 6‑85: Market Value by Region, Arterial Stent Market, Global, 2020 – 2030 (US$M)
Figure 6‑86: Bare-Metal Stent Market by Segment, Global, 2020 – 2030 (US$M)
Figure 6‑87: Total Bare-Metal Stent Market, Global, 2020 – 2030
Figure 6‑88: Units Sold by Region, Bare-Metal Stent Market, Global, 2020 – 2030
Figure 6‑89: Average Selling Price by Region, Bare-Metal Stent Market, Global, 2020 – 2030 (US$)
Figure 6‑90: Market Value by Region, Bare-Metal Stent Market, Global, 2020 – 2030 (US$M)
Figure 6‑91: Bare-Metal Carotid Stent Market, Global, 2020 – 2030
Figure 6‑92: Units Sold by Region, Bare-Metal Carotid Stent Market, Global, 2020 – 2030
Figure 6‑93: Average Selling Price by Region, Bare-Metal Carotid Stent Market, Global, 2020 – 2030 (US$)
Figure 6‑94: Market Value by Region, Bare-Metal Carotid Stent Market, Global, 2020 – 2030 (US$M)
Figure 6‑95: Bare-Metal Iliac Stent Market, Global, 2020 – 2030
Figure 6‑96: Units Sold by Region, Bare-Metal Iliac Stent Market, Global, 2020 – 2030
Figure 6‑97: Average Selling Price by Region, Bare-Metal Iliac Stent Market, Global, 2020 – 2030 (US$)
Figure 6‑98: Market Value by Region, Bare-Metal Iliac Stent Market, Global, 2020 – 2030 (US$M)
Figure 6‑99: Bare-Metal Renal Stent Market, Global, 2020 – 2030
Figure 6‑100: Units Sold by Region, Bare-Metal Renal Stent Market, Global, 2020 – 2030
Figure 6‑101: Average Selling Price by Region, Bare-Metal Renal Stent Market, Global, 2020 – 2030 (US$)
Figure 6‑102: Market Value by Region, Bare-Metal Renal Stent Market, Global, 2020 – 2030 (US$M)
Figure 6‑103: Bare-Metal Fem-Pop Stent Market, Global, 2020 – 2030
Figure 6‑104: Units Sold by Region, Bare-Metal Fem-Pop Stent Market, Global, 2020 – 2030
Figure 6‑105: Average Selling Price by Region, Bare-Metal Fem-Pop Stent Market, Global, 2020 – 2030 (US$)
Figure 6‑106: Market Value by Region, Bare-Metal Fem-Pop Stent Market, Global, 2020 – 2030 (US$M)
Figure 6‑107: Bare-Metal Infra-Pop Stent Market, Global, 2020 – 2030
Figure 6‑108: Units Sold by Region, Bare-Metal Infra-Pop Stent Market, Global, 2020 – 2030
Figure 6‑109: Average Selling Price by Region, Bare-Metal Infra-Pop Stent Market, Global, 2020 – 2030 (US$)
Figure 6‑110: Market Value by Region, Bare-Metal Infra-Pop Stent Market, Global, 2020 – 2030 (US$M)
Figure 6‑111: Covered Stent Market, Global, 2020 – 2030
Figure 6‑112: Units Sold by Region, Covered Stent Market, Global, 2020 – 2030
Figure 6‑113: Average Selling Price by Region, Covered Stent Market, Global, 2020 – 2030 (US$)
Figure 6‑114: Market Value by Region, Covered Stent Market, Global, 2020 – 2030 (US$M)
Figure 6‑115: Drug-Eluting Stent Market, Global, 2020 – 2030
Figure 6‑116: Units Sold by Region, Drug-Eluting Stent Market, Global, 2020 – 2030
Figure 6‑117: Average Selling Price by Region, Drug-Eluting Stent Market, Global, 2020 – 2030 (US$)
Figure 6‑118: Market Value by Region, Drug-Eluting Stent Market, Global, 2020 – 2030 (US$M)
Figure 6‑119: Venous Stent Market, Global, 2020 – 2030
Figure 6‑120: Units Sold by Region, Venous Stent Market, Global, 2020 – 2030
Figure 6‑121: Average Selling Price by Region, Venous Stent Market, Global, 2020 – 2030 (US$)
Figure 6‑122: Market Value by Region, Venous Stent Market, Global, 2020 – 2030 (US$M)
Figure 6‑123: Leading Competitors, Peripheral Vascular Stent Market, Global, 2023

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

Overall, the global peripheral vascular stent market was valued at $2.7 million in 2023. This is expected to increase over the forecast period at a CAGR of 3.1% to reach $3.3 million.

  • 2024
  • 10 Years
  • Global
  • MedCore
  • 2023/11/06
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library